News and information of Singapore stock market. Chart with Support and Resistance. A blog to force myself to learn.
Feb 13, 2014
Religare Health Trust operations remained strong
3Q14 results within expectations. 3Q14 DPU was 2.14 Scts, which was in line with our expectations. Revenue improved by 1.3% q-o-q, but was 1.8% below its IPO projections due to a weaker INR. In INR terms, however, revenue was 11% higher than projected. Operating margins improved marginally to 59% in 3Q14 from 58.1% in 2Q14, arising from tighter cost control.
Operations remained strong. The average occupancy at its Clinical Establishments remained high at 78%, up from 3Q13’s 73%, but down from 2Q14’s 86%, as 2Q is a seasonally high quarter due to the summer months. Average Revenue per Operating Bed (ARPOB), however, saw an increase of 5.1% from 2Q14 mainly from price increases in Mulund CE and higher intensities at Kalyan CE.
Our View
1H15 distributions hedged at SGD/INR53.36. In Dec’13, RHT entered into forward contracts to hedge distributions for the 6- month period ending
30 Sep’14, at SGD/INR53.36. This is a step down from the SGD/INR47.79 rate for the preceding 6-month period ending 31 Mar’14. As a result a weaker INR, we project DPU to dip to 7.2 Scts in FY15F from 8.1 Scts in FY14F. We estimate that every 1% change in SGD/INR rate will impact DPU by 1% correspondingly.
Delivering on growth through acquisitions, expansions and Greenfield projects. RHT recently entered into a sale deed to acquire Mohali Clinical Establishment (CE) for S$58.2m (INR2,850m). This facility is an accredited hospital in North India and will help to enhance RHT’s distribution yield. To aid growth from FY16 onwards, RHT held a groundbreaking ceremony to develop a women’s hospital in Ludhiana and is looking to expand BG Road CE by another 200 beds.
Recommendation
Maintain HOLD, TP revised to S$0.82. We have factored in the recently announced proposed acquisition of the Mohali Clinical Establishment for INR2,850m. Our TP is adjusted up marginally to S$0.82, based on DDM (CoE: 12.2%, t=3%), to account for the acquisition. Maintain HOLD. A key upside risk to our recommendation is a significant strengthening of INR against SGD.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment